Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The institution will be spread over an area of more than 8 acres
Women emerge as the cornerstone of this monumental undertaking
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The inspection was concluded with few procedural observations
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The company will provide comprehensive response to USFDA for the observations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
